• KOL
  • arrow_forward_ios Disease
  • arrow_forward_ios Myocardial
  • arrow_forward_ios Myocardial Infarction
  • arrow_forward_ios Alice K Jacobs
  • Alice K Jacobs

    Alice K Jacobs

    Myocardial Infarction  |  Cardiogenic Shock |  Practice Guidelines |  Coronary Angioplasty |  Dynamic Registry

    Alice K Jacobs

    • Alice K Jacobs: Influence Statistics
    • See prominent publications
    • Tools

     

    Prominent publications by Alice K Jacobs

    A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI fo


    [ PUBLICATION ]
    KOL Index score: 19209

    OBJECTIVES: This study sought to determine the effect of radial access on outcomes in women undergoing percutaneous coronary intervention (PCI) using a registry-based randomized trial.

    BACKGROUND: Women are at increased risk of bleeding and vascular complications after PCI. The role of radial access in women is unclear.

    METHODS: Women undergoing cardiac catheterization or PCI were randomized to radial or femoral arterial access. Data from the CathPCI Registry and trial-specific data were ...

    Also Ranks for: Radial Access |  women pci |  coronary intervention |  undergoing percutaneous |  vascular complications

    Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: Results from TIMI II


    [ PUBLICATION ]
    KOL Index score: 18329

    OBJECTIVES: The aim of this study was to determine the incidence and significance of second- or third-degree heart block among patients with inferior myocardial infarction treated with thrombolytic therapy.

    BACKGROUND: Data from the prethrombolytic era suggest that heart block occurs in approximately 20% of patients with acute inferior myocardial infarction and is associated with a marked increase in mortality. Little is known about the incidence and prognostic implications of heart ...

    Also Ranks for: Heart Block |  thrombolytic therapy |  myocardial infarction |  prognostic implications |  increased mortality patients

    Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: Insights from the coronary angioplasty versus excisional atherectomy trial (CAVEAT)


    [ PUBLICATION ]
    KOL Index score: 16885

    OBJECTIVES: We examined the results of the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT) to determine the characteristics and consequences of creatine kinase (CK) and creatine kinase, MB myocardial isoenzyme fraction (CK-MB) elevations after percutaneous coronary intervention.

    BACKGROUND: Enzyme elevations after interventional procedures have usually been thought to be without long-term clinical consequences. However, recent preliminary reports have suggested that ...

    Also Ranks for: Myocardial Infarction |  coronary intervention |  atherectomy trial |  creatine kinase |  angioplasty versus

    Culprit Vessel Percutaneous Coronary Intervention Versus Multivessel and Staged Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease


    [ PUBLICATION ]
    KOL Index score: 16731

    OBJECTIVES: The purpose of this study was to examine the differences in in-hospital and longer-term mortality for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease as a function of whether they underwent single-vessel (culprit vessel) percutaneous coronary interventions (PCIs) or multivessel PCI.

    BACKGROUND: The optimal treatment of patients with STEMI and multivessel disease is of continuing interest in the era of drug-eluting stents.

    METHODS: STEMI ...

    Also Ranks for: Multivessel Disease |  culprit vessel |  infarction patients |  pci procedure |  percutaneous coronary

    Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry


    [ PUBLICATION ]
    KOL Index score: 15877

    OBJECTIVES: We sought to investigate the potential benefit of thrombolytic therapy (TT) and intra-aortic balloon pump counterpulsation (IABP) on in-hospital mortality rates of patients enrolled in a prospective, multi-center Registry of acute myocardial infarction (MI) complicated by cardiogenic shock (CS).

    BACKGROUND: Retrospective studies suggest that patients suffering from CS due to MI have lower in-hospital mortality rates when IABP support is added to TT. This hypothesis has not ...

    Also Ranks for: Cardiogenic Shock |  iabp hospital |  aortic balloon |  acute myocardial infarction |  thrombolytic therapy

    Factors Related to the Selection of Surgical Versus Percutaneous Revascularization in Diabetic Patients With Multivessel Coronary Artery Disease in the BARI 2D (Bypass Angioplasty Revascularization In


    [ PUBLICATION ]
    KOL Index score: 15570

    OBJECTIVES: We evaluated demographic, clinical, and angiographic factors influencing the selection of coronary artery bypass graft (CABG) surgery versus percutaneous coronary intervention (PCI) in diabetic patients with multivessel coronary artery disease (CAD) in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial.

    BACKGROUND: Factors guiding selection of mode of revascularization for patients with diabetes mellitus and multivessel CAD are not ...

    Also Ranks for: Bari 2d |  diabetic patients |  type 2 diabetes |  coronary artery |  angioplasty revascularization

    Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock


    [ PUBLICATION ]
    KOL Index score: 14939

    BACKGROUND: The leading cause of death in patients hospitalized for acute myocardial infarction is cardiogenic shock. We conducted a randomized trial to evaluate early revascularization in patients with cardiogenic shock.

    METHODS: Patients with shock due to left ventricular failure complicating myocardial infarction were randomly assigned to emergency revascularization (152 patients) or initial medical stabilization (150 patients). Revascularization was accomplished by either ...

    Also Ranks for: Cardiogenic Shock |  early revascularization |  myocardial infarction |  mortality 30 |  percent patients

    Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators.


    [ PUBLICATION ]
    KOL Index score: 14517

    BACKGROUND: Cardiogenic shock remains the leading cause of death of patients hospitalized with acute myocardial infarction (MI). This study was conducted to examine (1) the current spectrum of cardiogenic shock, (2) the proportion of patients who are potential candidates for a trial of early revascularization, and (3) the apparent impact of early revascularization on mortality.

    METHODS AND RESULTS: Nineteen participating centers in the United States and Belgium prospectively registered ...

    Also Ranks for: Early Revascularization |  cardiogenic shock |  lower mortality |  patients cardiac catheterization |  angioplasty balloon

    Comparison of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting After Acute Myocardial Infarction Complicated by Cardiogenic Shock


    [ PUBLICATION ]
    KOL Index score: 14257

    BACKGROUND: The Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial demonstrated the survival advantage of emergency revascularization versus initial medical stabilization in patients developing cardiogenic shock after acute myocardial infarction. The relative merits of coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) in patients with shock have not been defined. The objective of this analysis was to compare the ...

    Also Ranks for: Cardiogenic Shock |  pci cabg |  coronary artery |  acute myocardial infarction |  emergency revascularization

    Association of Door-In to Door-Out Time With Reperfusion Delays and Outcomes Among Patients Transferred for Primary Percutaneous Coronary Intervention


    [ PUBLICATION ]
    KOL Index score: 13902

    CONTEXT: Patients with ST-elevation myocardial infarction (STEMI) requiring interhospital transfer for primary percutaneous coronary intervention (PCI) often have prolonged overall door-to-balloon (DTB) times from first hospital presentation to second hospital PCI. Door-in to door-out (DIDO) time, defined as the duration of time from arrival to discharge at the first or STEMI referral hospital, is a new clinical performance measure, and a DIDO time of 30 minutes or less is recommended to ...

    Also Ranks for: Dido Time |  30 minutes |  patients transferred |  reperfusion delays |  primary pci

    One-Year Survival Following Early Revascularization for Cardiogenic Shock


    [ PUBLICATION ]
    KOL Index score: 13879

    CONTEXT: Cardiogenic shock (CS) is the leading cause of death for patients hospitalized with acute myocardial infarction (AMI).

    OBJECTIVE: To assess the effect of early revascularization (ERV) on 1-year survival for patients with AMI complicated by CS.

    DESIGN: The SHOCK (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock) Trial, an unblinded, randomized controlled trial from April 1993 through November 1998.

    SETTING: Thirty-six referral centers with angioplasty ...

    Also Ranks for: Cardiogenic Shock |  early revascularization |  year survival |  ims erv |  death patients

    Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction A report from the SHOCK Trial Registry


    [ PUBLICATION ]
    KOL Index score: 13779

    OBJECTIVES: The aim of this study was to assess the impact of gender on clinical course and in-hospital mortality in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI).

    BACKGROUND: Previous studies have demonstrated higher mortality for women compared with men with ST elevation myocardial infarctions and higher rates of CS after AMI. The influence of gender and its interaction with various treatment strategies on clinical outcomes once CS develops is ...

    Also Ranks for: Cardiogenic Shock |  acute myocardial infarction |  gender differences |  mortality women |  hospital patients

    Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease


    [ PUBLICATION ]
    KOL Index score: 13412

    BACKGROUND: This investigation compares the results of contemporary percutaneous coronary intervention (PCI) with standard balloon angioplasty among patients with multivessel coronary disease. Patients having balloon angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI) and those within the Dynamic Registry meeting BARI eligibility criteria were studied.

    METHODS AND RESULTS: Clinical features and in-hospital and 1-year outcomes of 857 BARI-eligible patients in the ...

    Also Ranks for: Balloon Angioplasty |  coronary artery |  patients multivessel disease |  contemporary pci |  1 year

    Nonemergency PCI at Hospitals with or without On-Site Cardiac Surgery


    [ PUBLICATION ]
    KOL Index score: 13368

    BACKGROUND: Emergency surgery has become a rare event after percutaneous coronary intervention (PCI). Whether having cardiac-surgery services available on-site is essential for ensuring the best possible outcomes during and after PCI remains uncertain.

    METHODS: We enrolled patients with indications for nonemergency PCI who presented at hospitals in Massachusetts without on-site cardiac surgery and randomly assigned these patients, in a 3:1 ratio, to undergo PCI at that hospital or at a ...

    Also Ranks for: Cardiac Surgery |  hospital site |  myocardial infarction |  12 months |  pci patients

    Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction


    [ PUBLICATION ]
    KOL Index score: 12876

    BACKGROUND: The benefits and risks of prolonged dual antiplatelet therapy may be different for patients with acute myocardial infarction (MI) compared with more stable presentations.

    OBJECTIVES: This study sought to assess the benefits and risks of 30 versus 12 months of dual antiplatelet therapy among patients undergoing coronary stent implantation with and without MI.

    METHODS: The Dual Antiplatelet Therapy Study, a randomized double-blind, placebo-controlled trial, compared 30 versus ...

    Also Ranks for: Dual Antiplatelet |  acute myocardial infarction |  continued thienopyridine |  stent thrombosis |  benefits risks

     

    Alice K Jacobs: Influence Statistics

    Sample of concepts for which Alice K Jacobs is among the top experts in the world.
    Concept World rank
    safepci safepci enrollment #1
    drug prescriptions lung #1
    302 trial patients #1
    stemi standardized approach #1
    relative risk noninferiority #1
    36 060 patients #1
    predominant shock patients #1
    renal insufficiency bleeding #1
    30day allcause rsrrs #1
    1 diagnostic laboratories #1
    reperfusion publication angioplasty #1
    early bms #1
    balloon college cardiology #1
    enduring trust #1
    acute coronary nstacs #1
    earlier 2012 auc #1
    studies humans cto #1
    databases status disparities #1
    concomitant ischemia #1
    angioplasty coronary constriction #1
    unique challenges optimal #1
    outlier transfers #1
    new narrowing #1
    4 12lead #1
    balloon ventricular dysfunction #1
    death induced hypoxia #1
    pci cto pci #1
    opportunity⁎⁎editorials #1
    adjusted rate death #1
    blood institute chf #1
    myocardial infarction occurs #1
    2012 auc terminology #1
    neointimal hyperplasia oct #1
    paradoxical coronary emboli #1
    standard balloon equipment #1
    cardiac sos #1
    fluoroscopy micropuncture #1
    1 year nstacs #1
    functional total occlusions #1
    rtpa occlusive thrombi #1
    revascularization national #1
    women publication angioplasty #1
    2002 guideline #1
    nstacss #1
    reactive hyperemia picso #1
    genderbased outcomes #1
    angiographic success patients #1
    successful cto pcis #1
    cardiovascular agents infarction #1
    pci 24 hospitals #1

    Key People For Myocardial Infarction

    Top KOLs in the world
    #1
    Braunwald Braunwald
    myocardial infarction heart failure atrial fibrillation
    #2
    Robert M Califf
    myocardial infarction thrombolytic therapy heart failure
    #3
    Frans J J Van de Werf
    myocardial infarction acute coronary thrombolytic therapy
    #4
    Eric J Topol
    myocardial infarction thrombolytic therapy coronary angioplasty
    #5
    Christian Wilhelm Hamm
    myocardial infarction aortic valve acute coronary syndromes
    #6
    Harlan M Krumholz
    heart failure united states acute myocardial infarction
    Select a search phrase   myocardial infarction , myocardial infarction patients , myocardial infarction stroke , myocardial infarctions , myocardial infarction 95

    Alice K Jacobs:Expert Impact

    Concepts for whichAlice K Jacobshas direct influence:Myocardial infarction,  Cardiogenic shock,  Practice guidelines,  Coronary angioplasty,  Dynamic registry,  Percutaneous coronary,  Coronary intervention,  Coronary artery.

    Alice K Jacobs:KOL impact

    Concepts related to the work of other authors for whichfor which Alice K Jacobs has influence:Atrial fibrillation,  Heart failure,  Myocardial infarction,  Cardiogenic shock,  Coronary artery,  Cardiovascular disease,  Aortic valve.


     

    Tools

    Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


    Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts | Department of Cardiology' Boston Medical Center, MA (A.K.J.). | Boston Medical Center, Boston, Massachusetts. | Boston Medical Center, Boston, MA, USA | Departmen

    Copied to clipboard!

Key Opinion Leader (KOL) Means Ranked Lists of Experts
Therapeutic areas
  • Certain infectious and parasitic diseasesInfectious and parasitic
  • NeoplasmsNeoplasms
  • Endocrine, nutritional and metabolic diseasesEndocrine, nutritional and metabolic
  • Diseases of the nervous systemDiseases of the nervous system
  • Diseases of the eye and adnexaDiseases of the eye and adnexa
  • Diseases of the digestive systemDiseases of the digestive system
  • Diseases of the skin and subcutaneous tissueDiseases of the skin and subcutaneous tissue
  • Diseases of the genitourinary systemDiseases of the genitourinary system
  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classifiedSymptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
  • External causes of morbidity and mortalityExternal causes of morbidity and mortality
  • Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanismDiseases of the blood and blood-forming organs
  • Mental and behavioural disordersMental and behavioural disorders
  • Diseases of the ear and mastoid processDiseases of the ear and mastoid process
  • Diseases of the circulatory systemDiseases of the circulatory system
  • Diseases of the respiratory systemDiseases of the respiratory system
  • Diseases of the musculoskeletal system and connective tissueDiseases of the musculoskeletal system and connective tissue
  • Pregnancy, childbirth and the puerperiumPregnancy, childbirth and the puerperium
  • Certain conditions originating in the perinatal periodCertain conditions originating in the perinatal period
  • Congenital malformations, deformations and chromosomal abnormalitiesCongenital malformations, deformations and chromosomal abnormalities
  • Injury, poisoning and certain other consequences of external causesInjury, poisoning and certain other consequences of external causes
  • Factors influencing health status and contact with health servicesFactors influencing health status and contact with health services
  • Codes for special purposesCodes for special purposes
About KOL
  • About KOL
  • Learn more about our technology and how more and more universities, research organizations, and companies in all industries are using our data to lower their costs.
  • Why KOL?
  • Tutorials
  • KOL Jobs
  • KOL News
  • KOL Events
  • Become a Partner
  • Contact Us
  • Site Map
KOL New YorkKOL LondonDesktop
search KOL Search
search KOL Search
KOLs Data Cloud
  1. smart_toy
  2. KOL Guides arrow_forward
  3. Medical conferences arrow_forward
  4. KOLs #1 arrow_forward
  5. By Country arrow_forward
  6. Certain infectious and parasitic diseasesInfectious and parasitic
  7. NeoplasmsNeoplasms
  8. Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanismDiseases of the blood and blood-forming organs
  9. Endocrine, nutritional and metabolic diseasesEndocrine, nutritional and metabolic diseases
  10. Mental and behavioural disordersMental and behavioural disorders
  11. Diseases of the nervous systemDiseases of the nervous system
  12. Diseases of the eye and adnexaDiseases of the eye and adnexa
  13. Diseases of the ear and mastoid processDiseases of the ear and mastoid process
  14. Diseases of the circulatory systemDiseases of the circulatory system
  15. Diseases of the respiratory systemDiseases of the respiratory system
  16. Diseases of the digestive systemDiseases of the digestive system
  17. Diseases of the skin and subcutaneous tissueDiseases of the skin and subcutaneous tissue
  18. Diseases of the musculoskeletal system and connective tissueDiseases of the musculoskeletal system and connective tissue
  19. Diseases of the genitourinary systemDiseases of the genitourinary system
  20. Pregnancy, childbirth and the puerperiumPregnancy, childbirth and the puerperium
  21. Certain conditions originating in the perinatal periodCertain conditions originating in the perinatal period
  22. Congenital malformations, deformations and chromosomal abnormalitiesCongenital malformations, deformations and chromosomal abnormalities
  23. Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classifiedSymptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
  24. Injury, poisoning and certain other consequences of external causesInjury, poisoning and certain other consequences of external causes
  25. External causes of morbidity and mortalityExternal causes of morbidity and mortality
  26. Factors influencing health status and contact with health servicesFactors influencing health status and contact with health services
  27. Codes for special purposesCodes for special purposes
  28. About KOL arrow_forward
  29. Contact Us
    • KOL in English   
    • Deutsch   
    • Français   
    • Español   
    • 中国人   
    • 日本   
    • हिंदी   
    • Português   
    • Indo   
    • Norsk   
  1. Consult the KOL Community Resources
  2. High-quality guides curated by a team of professionals observing a rigorous review process.

    Our Health Guides highlight the work of the #1 KOLs for each Therapeutic Area.
  3. ADD/ADHD
    Stephen V Faraone - KOL #1 AdhdStephen V Faraone
    KOL #1 for Adhd
  4. Allergic conjunctivitis
    Mark B Abelson - KOL #1 Allergic ConjunctivitisMark B Abelson
    KOL #1 for Allergic Conjunctivitis
  5. Allergies
    Erika RM von Mutius - KOL #1 AllergiesErika RM von Mutius
    KOL #1 for Allergies
  6. Arthritis
    Rikard Holmdahl - KOL #1 ArthritisRikard Holmdahl
    KOL #1 for Arthritis
  7. Atrial fibrillation
    Gregory Yoke Hong Lip - KOL #1 Atrial FibrillationGregory Yoke Hong Lip
    KOL #1 for Atrial Fibrillation
  8. Babesiosis
    Peter J Krause - KOL #1 BabesiosisPeter J Krause
    KOL #1 for Babesiosis
  9. Breast Cancer
    Steven Alexander Narod - KOL #1 Breast CancerSteven Alexander Narod
    KOL #1 for Breast Cancer
  10. Cancer
    Anne Marie Tjønneland - KOL #1 CancerAnne Marie Tjønneland
    KOL #1 for Cancer
  11. DVT
    Harry Roger Büller - KOL #1 Deep Vein ThrombosisHarry Roger Büller
    KOL #1 for Deep Vein Thrombosis
  12. Encephalopathy
    Roger F Butterworth - KOL #1 EncephalopathyRoger F Butterworth
    KOL #1 for Encephalopathy
  13. Flea bites
    Bernard Joseph Hinnebusch - KOL #1 Flea BitesBernard Joseph Hinnebusch
    KOL #1 for Flea Bites
  14. Hemiparesis
    Jean‐Michel Gracies - KOL #1 HemiparesisJean‐Michel Gracies
    KOL #1 for Hemiparesis
  15. Nasal Vestibulitis
    Mario E Lacouture - KOL #1 Nasal VestibulitisMario E Lacouture
    KOL #1 for Nasal Vestibulitis
  16. See More ...
  1. About KOL
  2. Learn more about our technology and how more and more universities, research organizations, and companies in all industries are using our data to lower their costs.
  3. Why KOL?
  4. Tutorials
  5. KOL Jobs
  6. KOL News
  7. KOL Events
  8. Become a Partner
  9. Contact Us
  10. Site Map
  • Pfizer
  • Johnson & Johnson
  • Roche
  • Havas
  • AbbVie
  • Bristol Myers Squibb
  • Sanofi
  • Canada
  • France
  • Germany
  • India
  • Taiwan
  • Türkiye
  • United Kingdom (UK)
  • United States

  • Products and pricing

    • KOL Marketing Cloud pricing
    • Site Map
  • Privacy

    • Privacy policy
    • Acceptable use policy
  • Linguistics

    • KOL In English
    • Turkish
    • Spanish
    • Hindi
    • Hebrew
  • Device KOLs

    • Desktop computer
    • Mobile devices
  • North America

    • Manhattan
    • New York
    • Mexico
    • Toronto
    • Montreal
  • Europe

    • United Kingdom
    • London
    • Paris
    • Madrid
  • Asia - Pacific

    • Kolkata
Download on the App StoreGet it on Google Play

Copyright © 2023 - KOL , Helping you Find Meaning In English and 1000's other locales/cores.

KOL does not provide healthcare advice, medical diagnosis or treatment.

KOL
641 Avenue of the America's
New York, NY 10011
United States of America
KOL
2400 SE Washington Blvd.
Bartlesville, OK 74006
United States of America